位置:首页 > 蛋白库 > NOTUM_DROME
NOTUM_DROME
ID   NOTUM_DROME             Reviewed;         671 AA.
AC   Q9VUX3; Q8T385;
DT   29-APR-2015, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 3.
DT   03-AUG-2022, entry version 136.
DE   RecName: Full=Palmitoleoyl-protein carboxylesterase NOTUM {ECO:0000305};
DE            EC=3.1.1.98 {ECO:0000250|UniProtKB:Q6P988};
DE   AltName: Full=Protein Notum {ECO:0000303|PubMed:12015973};
DE   AltName: Full=Protein wingful {ECO:0000303|PubMed:12000788};
DE   AltName: Full=dNOTUM {ECO:0000303|PubMed:25731175};
DE   Flags: Precursor;
GN   Name=Notum {ECO:0000303|PubMed:12015973, ECO:0000312|FlyBase:FBgn0044028};
GN   Synonyms=wf {ECO:0000303|PubMed:12000788};
GN   ORFNames=CG13076 {ECO:0000312|FlyBase:FBgn0044028};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=12015973; DOI=10.1016/s1534-5807(02)00180-6;
RA   Giraldez A.J., Copley R.R., Cohen S.M.;
RT   "HSPG modification by the secreted enzyme Notum shapes the Wingless
RT   morphogen gradient.";
RL   Dev. Cell 2:667-676(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=12000788; DOI=10.1101/gad.991802;
RA   Gerlitz O., Basler K.;
RT   "Wingful, an extracellular feedback inhibitor of Wingless.";
RL   Genes Dev. 16:1055-1059(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   PRELIMINARY FUNCTION.
RX   PubMed=15469839; DOI=10.1016/j.devcel.2004.08.005;
RA   Kreuger J., Perez L., Giraldez A.J., Cohen S.M.;
RT   "Opposing activities of Dally-like glypican at high and low levels of
RT   Wingless morphogen activity.";
RL   Dev. Cell 7:503-512(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=20412775; DOI=10.1016/j.devcel.2010.02.015;
RA   Ayers K.L., Gallet A., Staccini-Lavenant L., Therond P.P.;
RT   "The long-range activity of Hedgehog is regulated in the apical
RT   extracellular space by the glypican Dally and the hydrolase Notum.";
RL   Dev. Cell 18:605-620(2010).
RN   [7]
RP   FUNCTION.
RX   PubMed=22872085; DOI=10.1242/dev.078402;
RA   Ayers K.L., Mteirek R., Cervantes A., Lavenant-Staccini L., Therond P.P.,
RA   Gallet A.;
RT   "Dally and Notum regulate the switch between low and high level Hedgehog
RT   pathway signalling.";
RL   Development 139:3168-3179(2012).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 82-415 AND 598-617, FUNCTION,
RP   SUBCELLULAR LOCATION, GLYCOSYLATION AT ASN-95, AND MUTAGENESIS OF SER-237.
RX   PubMed=25731175; DOI=10.1038/nature14259;
RA   Kakugawa S., Langton P.F., Zebisch M., Howell S.A., Chang T.H., Liu Y.,
RA   Feizi T., Bineva G., O'Reilly N., Snijders A.P., Jones E.Y., Vincent J.P.;
RT   "Notum deacylates Wnt proteins to suppress signalling activity.";
RL   Nature 519:187-192(2015).
CC   -!- FUNCTION: Carboxylesterase that acts as a key negative regulator of the
CC       Wnt signaling pathway by specifically mediating depalmitoleoylation of
CC       WNT proteins. Serine palmitoleoylation of WNT proteins is required for
CC       efficient binding to frizzled receptors (PubMed:25731175). Also acts as
CC       a regulator of long-range activity of Hedgehog (hh), possibly by
CC       regulating the switch between low and high level hh pathway signaling
CC       (PubMed:20412775, PubMed:22872085). {ECO:0000250|UniProtKB:Q6P988,
CC       ECO:0000269|PubMed:20412775, ECO:0000269|PubMed:22872085,
CC       ECO:0000269|PubMed:25731175}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[Wnt protein]-O-(9Z)-hexadecenoyl-L-serine + H2O = (9Z)-
CC         hexadecenoate + [Wnt protein]-L-serine + H(+); Xref=Rhea:RHEA:45340,
CC         Rhea:RHEA-COMP:11170, Rhea:RHEA-COMP:11171, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:32372,
CC         ChEBI:CHEBI:85189; EC=3.1.1.98;
CC         Evidence={ECO:0000250|UniProtKB:Q6P988};
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:12000788,
CC       ECO:0000269|PubMed:12015973, ECO:0000269|PubMed:25731175}. Cell surface
CC       {ECO:0000269|PubMed:25731175}. Note=Associates with the cell surface
CC       via interaction with sulfated CAG chains on glypicans.
CC       {ECO:0000269|PubMed:25731175}.
CC   -!- INDUCTION: Expression is induced by Wnt. {ECO:0000269|PubMed:12000788,
CC       ECO:0000269|PubMed:12015973}.
CC   -!- SIMILARITY: Belongs to the pectinacetylesterase family. Notum
CC       subfamily. {ECO:0000305}.
CC   -!- CAUTION: The molecular function of NOTUM has remained unclear for many
CC       years. It was initially thought to hydrolyze glycosaminoglycan (GAG)
CC       chains of glypicans, thereby affecting glypicans ability to interact
CC       with Wnt ligands (PubMed:12015973, PubMed:12000788). It was later
CC       reported to trigger glypican shedding, by mediating cleavage of their
CC       GPI-anchor (PubMed:15469839). However, while NOTUM specifically inhibit
CC       the Wnt signaling pathway, more pleiotropic effects would be expected
CC       from an enzyme affecting glypicans. It was finally shown that it
CC       requires glypicans to suppress Wnt signaling, but does not cleave their
CC       GPI-anchor (PubMed:25731175). It acts by mediating depalmitoleoylation
CC       of WNT proteins, impairing WNT binding to frizzled receptors
CC       (PubMed:25731175). {ECO:0000269|PubMed:25731175,
CC       ECO:0000305|PubMed:12000788, ECO:0000305|PubMed:12015973,
CC       ECO:0000305|PubMed:15469839}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=The art of biocuration
CC       - Issue 177 of March 2016;
CC       URL="https://web.expasy.org/spotlight/back_issues/177/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ457833; CAD29885.1; -; mRNA.
DR   EMBL; AY078993; AAL85497.1; -; mRNA.
DR   EMBL; AE014296; AAF49550.3; -; Genomic_DNA.
DR   RefSeq; NP_730096.2; NM_168643.3.
DR   PDB; 4UZJ; X-ray; 2.40 A; A/B=86-415, A/B=598-617.
DR   PDB; 4UZK; X-ray; 1.90 A; A/B=82-415, A/B=598-617.
DR   PDBsum; 4UZJ; -.
DR   PDBsum; 4UZK; -.
DR   AlphaFoldDB; Q9VUX3; -.
DR   SMR; Q9VUX3; -.
DR   DIP; DIP-61510N; -.
DR   IntAct; Q9VUX3; 2.
DR   STRING; 7227.FBpp0075193; -.
DR   ESTHER; drome-q9vux3; Pectinacetylesterase-Notum.
DR   GlyGen; Q9VUX3; 4 sites.
DR   iPTMnet; Q9VUX3; -.
DR   PaxDb; Q9VUX3; -.
DR   PRIDE; Q9VUX3; -.
DR   EnsemblMetazoa; FBtr0075435; FBpp0075193; FBgn0044028.
DR   GeneID; 39751; -.
DR   KEGG; dme:Dmel_CG13076; -.
DR   UCSC; CG13076-RA; d. melanogaster.
DR   CTD; 147111; -.
DR   FlyBase; FBgn0044028; Notum.
DR   VEuPathDB; VectorBase:FBgn0044028; -.
DR   eggNOG; KOG4287; Eukaryota.
DR   GeneTree; ENSGT00940000173033; -.
DR   HOGENOM; CLU_026533_1_1_1; -.
DR   InParanoid; Q9VUX3; -.
DR   OMA; FYLRKQP; -.
DR   OrthoDB; 610784at2759; -.
DR   PhylomeDB; Q9VUX3; -.
DR   BRENDA; 3.1.1.98; 1994.
DR   Reactome; R-DME-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-DME-5362798; Release of Hh-Np from the secreting cell.
DR   Reactome; R-DME-8957275; Post-translational protein phosphorylation.
DR   BioGRID-ORCS; 39751; 0 hits in 1 CRISPR screen.
DR   GenomeRNAi; 39751; -.
DR   PRO; PR:Q9VUX3; -.
DR   Proteomes; UP000000803; Chromosome 3L.
DR   Bgee; FBgn0044028; Expressed in saliva-secreting gland and 2 other tissues.
DR   Genevisible; Q9VUX3; DM.
DR   GO; GO:0009986; C:cell surface; IEA:UniProtKB-SubCell.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:1990699; F:palmitoleyl hydrolase activity; ISS:UniProtKB.
DR   GO; GO:0048546; P:digestive tract morphogenesis; IMP:FlyBase.
DR   GO; GO:0006507; P:GPI anchor release; IMP:FlyBase.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:UniProtKB.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; IMP:FlyBase.
DR   GO; GO:1990697; P:protein depalmitoleylation; ISS:UniProtKB.
DR   GO; GO:0048076; P:regulation of compound eye pigmentation; IMP:FlyBase.
DR   GO; GO:0007419; P:ventral cord development; HMP:FlyBase.
DR   GO; GO:0035220; P:wing disc development; IMP:FlyBase.
DR   GO; GO:0048190; P:wing disc dorsal/ventral pattern formation; IGI:FlyBase.
DR   GO; GO:0035222; P:wing disc pattern formation; IMP:FlyBase.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR004963; PAE/NOTUM.
DR   PANTHER; PTHR21562; PTHR21562; 1.
DR   Pfam; PF03283; PAE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Glycoprotein; Hydrolase; Reference proteome; Secreted;
KW   Serine esterase; Signal; Wnt signaling pathway.
FT   SIGNAL          1..46
FT                   /evidence="ECO:0000255"
FT   CHAIN           47..671
FT                   /note="Palmitoleoyl-protein carboxylesterase NOTUM"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000432994"
FT   REGION          411..592
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        411..426
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        466..483
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        499..545
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        237
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:Q6P988"
FT   ACT_SITE        338
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:Q6P988"
FT   ACT_SITE        384
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:Q6P988"
FT   CARBOHYD        95
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:25731175,
FT                   ECO:0007744|PDB:4UZJ, ECO:0007744|PDB:4UZK"
FT   CARBOHYD        372
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        578
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        612
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   MUTAGEN         237
FT                   /note="S->A: Impaired ability to inhibit the Wnt signaling
FT                   pathway."
FT                   /evidence="ECO:0000269|PubMed:25731175"
FT   STRAND          88..92
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   STRAND          107..111
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   STRAND          118..123
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   HELIX           132..141
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   HELIX           143..145
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   STRAND          153..155
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   HELIX           159..161
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   TURN            165..167
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   TURN            169..173
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   STRAND          174..179
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   STRAND          183..185
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   STRAND          191..193
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   HELIX           207..218
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   HELIX           219..221
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   TURN            222..224
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   STRAND          229..236
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   HELIX           238..255
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   STRAND          262..270
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   HELIX           286..297
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   HELIX           303..308
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   STRAND          309..311
FT                   /evidence="ECO:0007829|PDB:4UZJ"
FT   HELIX           313..317
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   HELIX           319..322
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   HELIX           323..325
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   STRAND          330..333
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   HELIX           339..344
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   HELIX           353..369
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   TURN            370..372
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   STRAND          374..378
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   STRAND          380..384
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   HELIX           390..393
FT                   /evidence="ECO:0007829|PDB:4UZK"
FT   HELIX           402..412
FT                   /evidence="ECO:0007829|PDB:4UZK"
SQ   SEQUENCE   671 AA;  76937 MW;  0230294B1E754D94 CRC64;
     MAVEQIDKMA AKAGEATNKW IKPQQPLLTL LLLLATFSQL PAVCSSSILD AASLQEKDPL
     RDTSMNMIQR NYMVMHSASG SGDHSRSLKR ANLANTSITC NDGSHAGFYL RKHPSSKKWI
     VLLEGGWHCF DVRSCRSRWM RLRHLMTSSQ WPETRDVGGI LSPHPEENPY WHNANHVLIP
     YCSSDSWSGT RTEPDTSDRE NSWRFMGALI LRQVIAELIP VGLGRVPGGE LMLVGSSAGG
     MGVMLNLDRI RDFLVNEKKL QITVRGVSDS GWFLDREPYT PAAVASNEAV RQGWKLWQGL
     LPEECTKSYP TEPWRCYYGY RLYPTLKTPL FVFQWLFDEA QMRVDNVGAP VTPQQWNYIH
     EMGGALRSSL DNVSAVFAPS CIGHGVLFKR DWVNIKIDDI SLPSALRCWE HSTRSRRHDK
     LKRSTEPSTA VSHPEHANNQ RHQRHRQRLQ RQKHNNVAQS GGQQRKHNHL SKEEREERKR
     LRQEQRQRRK QRRRQQQQKK ANGGQEHRNK KDNSPKSSNG NDQRKQRRRQ QLTAEERQEQ
     RKRRRKAQQQ QMKMQREQPA AGVFLEASAP QKTRSSNNAS AGTKSKKRHR VPRVPEKCGL
     RLLERCSWPQ CNHSCPTLTN PMTGEEMRFL ELLTAFGLDI EAVAAALGVD MHTLNNMERT
     ELVNMLTQQA N
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025